Trial Profile

A Clinical Trial Gathering Insight of Patient Reported Factors That Influence Preference Following Once Daily Topical Treatment With LEO 90100 Aerosol Foam and Daivobet Gel in Subjects With Psoriasis Vulgaris

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 28 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone-dipropionate/calcipotriol
Indications Plaque psoriasis
Focus Registrational; Therapeutic Use
Acronyms PSO-INSIGHTFUL
Sponsors LEO Pharma

31 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
30 Jun 2015 Planned End Date changed from 1 May 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
30 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com